This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Vito Guagnano: Innovator in Biaryl Derivatives
Introduction
Vito Guagnano is a notable inventor based in Lecce, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit protein-protein interactions.
Latest Patents
Guagnano holds a patent for "Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors." This invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, which has potential applications in treating various diseases.
Career Highlights
Vito Guagnano is associated with Novartis AG, a leading global healthcare company. His work focuses on innovative solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Vincent Bordas and Cara Brocklehurst, who contribute to the collaborative efforts in research and development at Novartis AG.
Conclusion
Vito Guagnano's work in biaryl derivatives showcases his commitment to advancing pharmaceutical science. His innovative patent reflects the potential for significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile